Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre

被引:32
作者
Morin, Marie-Paule [1 ]
Quach, Caroline [2 ]
Fortin, Elise [2 ]
Chedeville, Gaelle [1 ]
机构
[1] McGill Univ, Div Rheumatol, Ctr Hlth, Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada
[2] McGill Univ, Div Infect Dis, Dept Pediat, Montreal Childrens Hosp,Hlth Ctr, Montreal, PQ H3H 1P3, Canada
关键词
vaccines; juvenile idiopathic arthritis; immunization; immunocompromised; RHEUMATIC-DISEASES; SAFETY; IMMUNOGENICITY; METHOTREXATE; EFFICACY; MEASLES; MUMPS; RISK;
D O I
10.1093/rheumatology/kes175
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methods. Consecutive JIA patients coming for their scheduled visit were included if they were between 2 and 18 years of age and if they had an available written immunization record. Descriptive statistics were used to evaluate the proportion of children with complete vaccination status according to the Quebec Immunization Protocol at 2.5, 10.5 years and at their last clinic visit. Results. A total of 200 patients were included. Complete vaccination according to schedule was identified in only 52% of patients at 2.5 years, 68% at 10.5 years and 61% at their last clinic visit. The vaccination coverage rate for individual vaccines was good overall with the exception of low measles, mumps and rubella vaccine coverage at 2.5 years (58%). Conclusion. Despite overall good vaccination coverage rate for individual vaccines, only 61% of our cohort had a complete vaccination status at their last clinic visit. Measures to optimize vaccination coverage, such as catch-up vaccination, should be implemented when possible.
引用
收藏
页码:2046 / 2050
页数:5
相关论文
共 15 条
[1]  
[Anonymous], ENQUETE COUVERTURE V
[2]   Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept [J].
Borte, S. ;
Liebert, U. G. ;
Borte, M. ;
Sack, U. .
RHEUMATOLOGY, 2009, 48 (02) :144-148
[3]  
Cassidy J.T., 2011, The textbook of pediatric rheumatology, V6th
[4]   Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists [J].
Curtis, Jeffrey R. ;
Patkar, Nivedita ;
Xie, Aiyuan ;
Martin, Carolyn ;
Allison, Jeroan J. ;
Saag, Michael ;
Shatin, Deborah ;
Saag, Kenneth G. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (04) :1125-1133
[5]   Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis [J].
Dell'Era, Laura ;
Corona, Fabrizia ;
Daleno, Cristina ;
Scala, Alessia ;
Principi, Nicola ;
Esposito, Susanna .
VACCINE, 2012, 30 (05) :936-940
[6]   Vaccination in patients with chronic rheumatic or autoimmune diseases [J].
Glueck, T. ;
Mueller-Ladner, U. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (09) :1459-1465
[7]   EULAR recommendations for vaccination in paediatric patients with rheumatic diseases [J].
Heijstek, M. W. ;
de Bruin, L. M. Ott ;
Bijl, M. ;
Borrow, R. ;
van der Klis, F. ;
Kone-Paut, I. ;
Fasth, A. ;
Minden, K. ;
Ravelli, A. ;
Abinun, M. ;
Pileggi, G. S. ;
Borte, M. ;
Wulffraat, N. M. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (10) :1704-1712
[8]   Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis [J].
Heijstek, Marloes W. ;
Pileggi, Gecilmara C. S. ;
Zonneveld-Huijssoon, Evelien ;
Armbrust, Wineke ;
Hoppenreijs, Esther P. A. H. ;
Uiterwaal, Cuno S. P. M. ;
Kuis, Wietse ;
Wulffraat, Nico M. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (10) :1384-1387
[9]   Hepatitis B vaccination in children with juvenile idiopathic arthritis [J].
Kasapçopur, Ö ;
Çullu, F ;
Kamburodlu-Goksel, A ;
Çam, H ;
Akdenizli, E ;
Çalykan, S ;
Sever, L ;
Arysoy, N .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (09) :1128-1130
[10]  
LIMA MELO JM, 2010, PED RHEUM EUR SOC C